Cargando…
维奈克拉治疗恶性血液病异基因造血干细胞移植后复发25例疗效及安全性
OBJEGTIVE: To investigate the efficacy and safety of preemptive/salvage therapy with venetoclax (VEN) in patients with recurrence after allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: Retrospective analysis the clinical data of 25 patients with minimal residual disease (MRD)...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395564/ https://www.ncbi.nlm.nih.gov/pubmed/36709130 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.07.003 |